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ABSTRACT 
 
Context: the role of endurance physical activity of moderate and high intensity in 
Parkinson’s disease patients in their mild to moderate phase (Hoehn and Yahr scale: 
I-III) regarding their cognitive functions. 
 
Objective: determine the typologies of aerobic physical activity that scientific evi-
dence has proved effective in enhancing and/or slowing down the decline of one or 
more of the cognitive domains as a consequence of the progression of Parkinson’s 
disease. Another objective is to assess whether a specific modality of aerobic exer-
cise could be proved, more effective than the others in terms of cognitive preserva-
tion, or even augmentation. 
 
Data sources: this review has been carried out by searching the following databases: 
PubMed, Cochrane Library and PEDro. Also, additional search has been carried out 
by screening the references of those articles already selected, in case other relevant 
articles would have been available from different sources. Search terms included: 
“Parkinson’s disease”, “aerobic exercise”, “cognition”, “cognitive”, “endurance”, 
“treadmill”, “BDNF” and “hippocampus”; these terms were inserted in the different 
databases search engines by connecting them with the Boolean term “AND”. 
  
Study selection: the studies selected were all those examining any eventual relation-
ship between aerobic physical activity, either alone or having a relevant major role in 
conjunction with other modalities of exercise, and the cognitive aspects of Parkin-
son’s disease. The search was limited to years 2008 to 2014. 
 
Data extraction: all the data were extracted from the selected material by the author 
of this thesis. The data that were taken into account were the method of research, the 
different types of implementations administered to the intervention group and the 
eventual sample group, the methods of assessment, the results and, when present the 
reasons of possible bias, including those expressed by the authors of the study them-
selves.  
 
Results: seven articles were included concerning moderate aerobic physical activity 
implementation in patients with Parkinson’s disease clinical diagnosis. 
 
Limitations: the main limitation were the restricted amount of time, this necessary to 
present this thesis in the agreed amount of time. A further limitation was the possibil-
 ity to access only to those articles which were free or requiring a minimum charge 
(<10 euros). Search strategy was also limited to only some databases instead of more 
comprehensive approach. 
 
Conclusions: all the studies shared the conclusion that a regime of aerobic physical 
activity in a population of patients in their mild stages of Parkinson’s disease is sig-
nificantly beneficial in enhancing and/or slowing down the decline of one or more of 
the cognitive domains. However, not all of the studies taken into consideration for 
this review reported the specific type of exercises included or the intensity range 
within which the activity had been proved to be effective. Future studies should re-
port more accurately these details and include at least one assessment test for each of 
the subcategories of cognition in order to determine whether one aerobic activity can 
be objectively considered more efficacious than another in the ambit of cognitive 
preservation. A more detailed description of the activities implemented (including 
doses, intensity range and eventual modifications, where these had been applied) 
would also improve the accessibility of these results also to the public, patients and 
caregivers included. More thorough systematic review would be beneficial. 
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1 INTRODUCTION 
Throughout the last decade, physical exercise has come into evidence as a way of 
treating and even preventing neurodegenerative conditions, Parkinson’s disease (PD) 
being one of those. Its benefits concerning this condition have been proven to span 
from the syndrome’s motor signs to, more recently, the non-motor ones. While it is 
now relatively easy to design a specific exercise plan addressed to the major motor 
symptoms a patient is exhibiting, the choice is not as clear cut when addressing the 
non-motor symptoms. Numerous studies on both animal models (Sung, 2012; Tuon, 
2012) and human patients (from the initial to the mild phase of PD) are available 
nowadays supporting specifically the validity of aerobic exercise, usually in the form 
of treadmill brisk walking/jogging. What, according to the author of this thesis, still 
remains unclear, is whether a specific modality has been proved, so far, more effec-
tive than another: in particular, when addressing the cognitive deficits of Parkinson’s 
disease, is a (relatively) high intensity aerobic training program more effective than a 
moderate one of the same type? Having some data concerning this difference may 
help on one side the patient and his/her caregivers to stay motivated in what should  
become a life style and not only a cure for a determinate about of time, and, where 
possible to upgrade it in intensity (provided that the benefits would largely outstand 
the risks). Similarly, further evidence of the neuroprotective role of aerobic activity 
would be an additional health promoting reminder of the importance of an active 
lifestyle at any age. Also, a clear display and perhaps a wider diffusion of the studies’ 
results, could positively influence the local competent committees to set funds to 
promote aerobic activity for this part of population. Finally, the author of this thesis 
finds of primary importance to make these results available for the population in-
volved, which means the mere publication of results on specialized journals may not 
be enough: instead, translating them into a more accessible and understandable mean 
of information, such as a leaflet, for example, and giving more than one alternative 
for the activity to be taken up, may play a key role in involving more the patient him-
self in his therapy: “why do I have to exercise?” or “it is too late/ I am too old” or “I 
do not like jogging” , “I cannot jogging for –put any reason here-“ and “it would not 
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make any difference now” would receive an answer in a layman language, leaving 
out technicisms.  
2 OBJECTIVES 
 
With this thesis, the author is aiming to present those exercises that clinical evidence 
has proved to promote an effective neuroprotective and/or neurotrophic action (ex-
pressed as maintained or even improve cognitive functionality) in individuals affect-
ed by Parkinson’s disease. The presence of this beneficial effect would have been 
assessed either by testing different domains of cognition or by laboratory tests meas-
uring the BDNF serum levels. The following review has been organized according to 
the PICOS principles and the articles had been graded according to the PEDro scale 
for quality (although one of the articles included, being a single case report, was not 
particularly suitable for this type of rating). 
The PICOS principles regard the population a particular treatment or therapy is di-
rected to, the intervention(s) that have been applied, the control(s), whenever present, 
the outcome observed from the intervention and the study typology. Pertinently to 
this review, the PICOS principles have been established as follows. 
Population: Idiopathic Parkinson’s disease patients; non-demented; in their mild to 
moderate stages of the disease (Hoehn & Yahr: from one to three).  
Interventions: aerobic/endurance exercise or aerobic/endurance and other training 
modalities. 
Controls: any other treatment or placebo. 
Outcome: any cognitive outcome or any significant increase in BDNF serum levels.  
Study design:  RCTs, CCTs and single cases of study have been included.  
Furthermore the author graded the articles included using the PEDro scaling system. 
 
3 PARKINSON’S DISEASE 
Parkinson’s disease was a condition already known for centuries as “Paralysis Agi-
tans”, shaking palsy, when, in 19th century, it got its current name by the French neu-
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rologist Jean-Martin Charcot, after Doctor James Parkinson, who first described it in 
a systematic way in the London of 1817 (Goetz, 2011). 
Parkinson’s disease (PD) is a chronic neurodegenerative condition affecting, in prev-
alence, but not exclusively, the dopaminergic neurons of the Substantia Nigra pars 
compacta (SNpc) (Jankovic, 2002) (see Picture 1).  
 
 
Picture 1. Sagittal section of a brain, with indication of the Midbrain and the location of the Substantia 
Nigra. A sample of Substantia Nigra from both a healthy and Parkinsonian brain is shown (reference: 
Dzamko, 2014). 
This degeneration is often accompanied by intracytoplasmatic protein aggregates, the 
so called Lewy Bodies. Parkinson’s disease is considered to be an age-related dis-
ease, although genetic autosomal, both dominant and recessive, forms of the syn-
drome have been observed and studied throughout the years, these affecting a young-
er minority of patients. Left out this minority, the majority of the patients is affected 
by the idiopathic form of Parkinson’s disease: for this, since no biomarker has yet 
been found, the diagnosis is based on hallmarks. (Jankovic, 2002) 
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3.1 Pathophysiology 
Despite the progresses in brain imaging and neurology in general, most cases of PD, 
have no specific causes, therefore the denomination of “Idiopathic PD”; what it is 
known, however, is the pathophysiology of this condition. Idiopathic Parkinson’s 
disease is characterized first of all by the depletion of dopaminergic neurons, mainly 
in the substantia nigra pars compacta (Zigmond, 2002). It has been proven, though, 
that the very first areas where the condition develops are others, precisely the vagus 
nerve (dorsal motor nucleus), the olfactory bulbs and nucleus, the locus coeruleus 
and only then the substantia nigra (Kwan, 2011).  
In order the PD hallmark symptoms and signs to develop, a major depletion of do-
paminergic neurons has to occur: this because, in the first phases, some compensato-
ry mechanisms (e.g. increase in the amount of dopamine synthesis and release in the 
remnants neurons) may still permit a normal functioning. With time, catechola-
minergic systems other than the dopaminergic can be involved, causing the devel-
opment of additional symptoms, including cognitive decline and dementia. (Zig-
mond, 2002) 
A second characteristic, pathological sign of this condition is the presence of intra-
cellular aggregates, denominated Lewy Bodies: these are of proteic and lipidic nature 
and can be observed, particularly, in those areas showing neural loss, although the 
relationship between these two phenomena is not fully understood (Cookson, 2009). 
Furthermore, it must be evidenced the presence of α-synuclein as component of the 
Lewy bodies in those individuals who suffered from idiopathic PD: this protein, 
which retains the propriety to self-aggregate in a not dissolvable fashion, is involved 
in the development of the Parkinson’s disease, although to which exact extent is still 
not known (Zigmond, 2002). 
It must be kept in mind, however, the fact that neither the neural loss nor the pres-
ence of these aggregates are sufficient determinants of the disease (Cookson, 2009). 
3.2 Etiology 
Despite the fact PD is diagnosed in the later decades of life, aging has not proved to 
be an etiologic factor for this condition. This is supported by the fact that striatal and 
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nigral dopaminergic neurons depletion occurs with different times and modalities in 
PD patients and healthy subjects. (Zigmond, 2002) 
In the etiology of idiopathic Parkinson’s disease both environmental and genetic fac-
tors have been hypothesized (Keus, 2014).  
3.2.1 Environmental factors 
Some environmental factors have been related to an increased risk to develop PD, 
there are most importantly, the neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine) being the most important. It causes symptoms so similar to those 
of PD and it has been used to create laboratory models of PD up to now. Also, other 
environmental factors recognized are exposure to well waters, pesticides (Rotenone), 
herbicides, industrial chemicals and metals, particularly long term exposure to man-
ganese, copper, alone or in combination with lead and/or iron. (Gorell, 1999) 
Viral etiology has been proposed for years, without ever coming to a satisfactory 
conclusion, not even with the encephalitis lethargica pandemic of the years 1916-
1926 which caused in many of the (few) survivors what it is agreed now to be a well 
distinct condition, currently named “Postencephalic Parkinsonism” (Jankovic, 2002). 
On the other hand, smoking and any form of caffeine seems to have inverse correla-
tion with the risk of developing PD (Jankovic, 2002), while the results concerning 
the integration of antioxidants in the diet has given mixed results: for instance, to-
copherol (vitamin E) assumption has proven not to be determinant in the prevention 
of the disorder (Molina, 1997).  
3.2.2 Genetic factors 
At first, different genetic mutations have been found to cause parkinsonism; howev-
er, the same studies helped to better understand the mechanisms behind idiopathic 
Parkinson’s disease as well (Huang, 2003). As the website of Parkinson’s disease 
Foundation (2015) reports, two categories of genes can be individuated concerning 
idiopathic PD etiology: “causal genes” which are proven to be enough to cause the 
disease, even without co-factors and “associated genes” which, although not directly 
causing the condition, predispose an individual to develop it. 
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Causal gene for PD is the one called SNCA, abbreviation for “synuclein, alpha (non 
A4 component of amyloid precursor)”, belonging to the PARK family of genes: it 
carries the instructions for the synthesis of α-synuclein. When SNCA shows some 
mutations (at least 18 mutations have been reported), this causes the production of 
misfolded or excessive α-synuclein, which in turn has been shown to be connected to 
the pathophysiology of PD. (Website of the Genetic Home Reference, 2012) This 
form of PD, however, remains very rare, involving about one or two percent of the 
clinical population (Website of Parkinson’s disease Foundation, 2015). 
Associated gene for PD is that named LRRK2 (“Leucine-rich repeat kinase 2”) re-
sponsible for the synthesis of the protein dardarin; the modifications this gene may 
exhibit are manifold, as well as the consequences in case of developing PD: age of 
onset spreading from the 30s to the 80s, disease-specific dementia development, etc 
(Website of Parkinson’s disease Foundation, 2015) 
However, it must also be taken into consideration that individuals belonging to the 
same familial nucleus and who developed the condition shared not only the genetic 
pool, but also similar behaviors and environment: therefore familial occurrence of 
any form of Parkinsonism may be due not only to genetic factors (Jankovic, 2002). 
3.3 Epidemiology 
According to the European Parkinson’s Disease Association (EPDA), about 6.3 mil-
lion people are currently diagnosed with Parkinson’s disease worldwide.  
In particular, Keus reports in 2014 that 1.2 million people are estimated to be affect-
ed with this condition throughout whole Europe. The same guideline predicts that, 
given the ageing rate of the population, this current number is destined to be doubled 
by 2030, while, for the incidence, the disease ratio is 1.5 times higher in men than in 
women. With the exclusion of some genetic forms of this condition, which have been 
observed to affect individuals even younger than 40 years old, the majority of diag-
nosis Parkinson’s disease is made in persons over the age of 60 years: this may be 
due, at least in part, to repetitive, prolonged exposure to predisposing factors (some 
of them have been listed before in this thesis), together with a decline, partly physio-
logically age-related, of the neurological repair and of those mechanisms responsible 
for toxins and oxidation byproducts disposal (Jankovic, 2002). 
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3.4 Incidence 
Only few surveys (Dorsey, 2007) have been carried out about Parkinson’s Disease 
prevalence at worldwide level: the results indicate the prevalence of this condition 
varies widely from one area of the globe to the other, although this is due to a com-
plex combination of factors, such as age distribution and life expectancy in that spe-
cific population, methods of diagnosis, possibility of access to health care facilities 
and to exposure to either predisposing or protective environmental factors 
(Muangpaisan, 2011). It has been estimated that PD is 1.5 – 2 times as common in 
men than women of similar age, independently from geographical location and/or 
race: this may be caused by multiple factors, such as greater exposure to environ-
mental risk factors, for instance those activity-related, different hormonal influence 
and ultimately, genetic mutations predisposing to the condition, which mostly occur 
on the X chromosome (Wooten, 2004). As for age distribution, PD is more common 
after the fifth decade of age, up to the age of 90, when it is seen to decline again, 
probably due to the small of this part of the population (de Lau, 2006).  
3.5 Diagnosis and classification 
Parkinson’s disease often presents with one or more typical hallmarks: bradykinesia, 
tremor at rest, often asymmetrical and starting from a very specific area (a finger, for 
example, where it can present also in a “pill-rolling”-fashion), muscle stiffness, with 
consequential difficulties when walking and, more in general, moving; also, impaired 
posture, mask-like face and micrographia are often present (Sharma, 2013). Diagnos-
ing Parkinson’s disease at an early stage is very difficult; on the other hand, with 
time and the development of the condition, the signs and symptoms become more 
evident and numerous (Calne, 1992). According to Hughes (1992), the diagnosis of 
Idiopathic Parkinson’s disease is carried out throughout three phases: in the first 
phase, the patient is referred to a specialist (usually a neurologist), in order to deter-
mine whether his/her symptoms and signs do actually fall into the wider group of 
parkinsonisms (which includes the ones listed just above); secondly, other possible 
causes for the patient’s condition will be ruled out, including head traumas, history of 
stroke, cerebral tumor, exposure to neurotoxins, the assumption of antipsychotics 
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and/or drugs affecting the uptake of dopamine, history of encephalitis, or other neu-
rological conditions.  
Further evidence for Idiopathic Parkinson’s Disease will be sought, instead, in the 
third phase of the diagnostic process; in particular, three or more of the following 
signs should be observed:  
 unilateral onset, together with perseverant asymmetry of the motor symp-
toms (or with the side where the onset took place being most affected);  
 resting tremor; 
 the disorder being degenerating progressively;  
 significant excellent response to levodopa, which, on the other hand, can 
be responsible of peak dose dyskinesia and/or chorea; 
 significant responsivity to levodopa for ≥5 years. 
 
According to the degree of disability shown by the patient at the moment of the neu-
rological examination, a classification of the stage of the condition can be made; the 
Hoehn and Yahr classification scale is the most used in clinical settings, mainly be-
cause of its easy and almost immediate applicability (see Table 1). 
  
Table 1: Hoehn and Yahr scale, detail. (Bhidayasiri, 2012) 
 
However, right because of this simplicity and the exclusive focus on motor symp-
toms and their consequences on the daily life, it must be always kept in mind that this 
scale is not comprehensive and bears no indication of non-motor symptoms. A modi-
fied version of this scale had been designed, including two further stages between 
grades one-two and two-three. However, despite the availability of this modified ver-
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sion, it is recommended to evaluate the context and the purpose of a given research 
to be carried out before opting for one or the other version. (Goetz, 2004) 
3.6 Motor symptoms. 
The most recurrent clinical signs of PD are bradykinesia (present in 77-98% of cas-
es), resting tremor (evident already in the beginning phase of the disease about in 
70% of cases, increasing then up to 100% of cases in the later stages); rigidity 
through the whole passive ROM, often accompanied by pain, is also common, recur-
ring in 89-99% of cases: this, in turn, may cause antalgic postural misalignment. 
(Keus, 2014). Furthermore, other hallmarks of the condition, although occurring usu-
ally in the later stages, are the loss of postural reflexes, these causing balance im-
pairments. One exemption, which can be evident even three years after the diagnosis, 
is the deterioration of the dynamic postural control, evidenced, in clinical assess-
ment, by asking the patient to turning of a 180 degrees angle (Keus, 2014).  
In addition, patients suffering either from idiopathic Parkinson’s disease or a form of 
Parkinsonism can exhibit also an irregular posture, in particular in the areas of neck, 
limbs or trunk; this is true for about a third of the patients, who most often present 
with a pathological flexion at hip and knee level, accompanied by shoulder protrac-
tion; other, postural anomalies can be encountered in this population of patients: 
camptocormic posture (see Picture 2), pleurothotonus/Pisa’s syndrome, antecollis 
and scoliosis are more serious and more disabling, whose cause, in relation to the 
Parkinson’s pathology, remains unsure, thus making its management challenging. 
(Doherty, 2011) 
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Picture2: Camptocormic posture (reference: http://en.wikipedia.org) 
 
Nevertheless, the ultimate confirm of the diagnosis will be possible only postmortem, 
by observation of the pathological signs such as the presence of alpha-synuclein 
positive Lewy bodies and the loss of pigmented neurons, particularly in the substan-
tia nigra pars compacta (SNpc). These motor hallmarks however, which, on average, 
will start to be evident only after about 50% of the dopaminergic neurons in the 
SNpc have been lost, are often the main target in PD treatment. The therapy for PD, 
in fact, mostly consists in replacing the lack of dopamine, due to the degeneration of 
those neurons responsible for its production, at first throughout dopamine agonist 
drugs and, later on, by adding Levodopa (L-dopa), a precursor of dopamine. Levo-
dopa will act on those motor hallmarks, but it will not affect other important common 
features often present in PD, such as freezing of gait, autonomic, cognitive, behav-
ioral and affective dysfunctions: on the opposite, besides other side effects, Levodo-
pa, more likely, will trigger or exacerbate some of them. (Sethi, 2008) 
3.7 Non motor symptoms 
Despite PD is diagnosed by the presence of clinical motor signs listed above, the 
“non-motor” deficits are just as important as the first ones, and just as well they can 
influence the quality of life of the patient and his/her family or caregivers, besides 
being one of the main reasons for a PD patient institutionalization. Under the term 
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non-motor symptoms is collected a heterogeneous group of dysfunctions, in particu-
lar related to cognitive, memory, attention, executive, visuospatial, autonomic and 
behavioral areas. It has been observed that patients exhibiting non-motor symptoms 
of Parkinson’s disease tend to be particularly more affected in one of these domains. 
(Litvan, 2011) 
3.7.1 Cognitive impairments 
Throughout the years, studies on both animal and human subjects have brought the 
scientific community to the observation that basal ganglia dysfunctions are one of the 
causes of cognitive and behavioral dysregulations. 
Concerning the cognitive domain, the main consequences from basal ganglia dys-
functions include a general slowing down in the processing of all the information re-
trieved from the environment, an inefficient retrieval of memories (sometimes more 
than actual memory loss), an impaired executive capacity and behavioral symptoms 
such as inertia, apathy and depressed mood (Jankovic, 2002). 
Put together, these signs make up what are the most recurrent observation and com-
plaints made by the family or the caregiver of the patient: forgetfulness, difficulty to 
concentrate (or “set maintenance”) and the difficulty in following conversations with 
more than one interlocutor (Jankovic, 2002). 
In the following paragraphs, the main cognitive areas, found to be most commonly 
impaired at some level in individuals suffering from PD, have been illustrated; as it 
shows, cognitive impairment in PD, although very common (up to 93% of the clini-
cal PD population, according to Pillon, 2001) and present from the very early stages 
of the disease, is more likely to interests very specific domains of cognition, these 
being memory, executive and visuospatial capacities. 
3.7.2 Memory impairments 
Memory is not a uniform one-way process. Research in the years has only been able 
to partially clarify the mechanisms behind it. In PD patients, both the “working 
memory” and the “long term memory” can result impaired. Working memory, that 
part of memory with the function of retaining newly acquired piece of information 
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waiting to be “filtered” and manipulated before being stored by the long term one, 
can result impaired by PD, also due to the incapacity or inefficiency of repressing 
secondary, interfering stimuli. This can be proved, for example, by poor results in 
short term recall tasks (eg. remembering as many items from a list) (Jankovic, 2002).  
 
Long term memory, on the other hand, can result impaired as well; the temporal-lobe 
controlled “strategies” aimed at storing the information, do not result particularly af-
fected in this category of patients, while, on the other hand, the organization, either 
temporal or according to other different associative conditions, can result impaired. 
Further inefficiencies can be recognized in the procedural learning, at variable ex-
tents, and in the internal control of attention, which also contributes to the inefficien-
cy at maintaining the attention to given stimuli. (Jankovic, 2002) 
3.7.3 Attention impairments 
Attention can be defined as the voluntary decision to select one particular infor-
mation, whether of the visual, auditory or any other sensory type, while ignoring as 
not important other stimuli occurring at the same time, in the same circumstance. At-
tention should not be confused with the concept of “arousal”, which, however, can be 
affected in Parkinson’s disease patients: while arousal describes a global attentive-
ness and readiness, which can be opposed to apathy, with “attention” clinicians refer 
usually to the conscious and voluntary choice to focus on a particular subject. (Selzer 
& Clarke, 2006). The psychologist William James wrote, back in 1890, that attention 
requires “withdrawal from some things in order to deal effectively with others…”. 
 Similarly, attention may play a relevant role in the learning process by helping ad-
dressing the subject’s mind on the task or notion that needs to be acquired (Selzer & 
Clarke, 2006). Cognitive impairment, including the attention functions, is not influ-
enced by dopamine levels alone, but more likely, by a precise equilibrium between 
dopamine, noradrenaline, serotonin and acetylcholine: this translates into the fact that 
the dopaminergic treatment addressed at the motor symptoms will be of no effect in 
addressing the non-motor ones (Solari, 2013).  
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3.7.4 Executive dysfunction 
Executive function can be regarded as an “umbrella” term, comprehensive of differ-
ent cognitive processes, such as setting the attention on a specific thing, maintaining 
this attention as long as it is necessary, flexible thinking, necessary to adapt ourselves 
efficiently to the ever-changing situations and also, once sat a goal, the capacity of 
the individual to act and behave according to that outcome requirements. This being 
said, it is clear how many different cognitive functions are necessary to maintain an 
efficient executive capacity. As a consequence of this quantity of different facets of 
cognition, many different specific tests will be needed (some of which will be further 
illustrated in appendix one), in order to conduct a satisfactory assessment of this 
sphere of cognition. The evidence we obtain from clinical settings (tests, scans, 
fmri,…) has stressed the importance of the frontal lobes in the ambit of disturbances 
and impairments of the executive area of cognition: this mainly because of the vast 
network of reciprocal links between cortical and subcortical strata in this specific ar-
ea of the brain, which would act as “supervisor” and “modulator” of the myriads of 
connections existing. Eventual frontal lobe damages are seen more in the everyday 
life than in the results coming from the most commonly used intelligence tests; in 
particular, some difficulties and impairments are observed more often in these indi-
viduals’ daily lives. Firstly, the patient is not able or has anyway difficulties in modi-
fying his behavior accordingly to changing situations/stimuli, as it can be evidenced 
by the “Wisconsin Cards Sorting out Test”. Secondly, in his daily life, the patient 
encounters difficulties in carrying out tasks composed by more than one finite action: 
the problem in these circumstances is not represented by the single “steps” making 
up the task as a whole, the difficulty resides instead in the capacity from him of plan-
ning and handling the “steps” as a sequence. Thirdly, the patient may result unable to 
sort out from a group of concomitant stimuli the single, most important one, and fo-
cus on that the response; this incapacity of telling the important stimulus from the 
secondary distractors can be assessed by the “Stroop Test”; it is also a primary cause 
of what is defined “Environmental Dependency Syndrome”, a condition in which the 
subject feels composedly forced to take and use any object he may see in a given set-
ting, although not asked to do so. Fourthly, the perseveration of a behavior, whether 
vocal or motor and even if as response of a previous stimulus is an indicator of pos-
sible dysexecutive syndrome, causing the patient to be unable to voluntarily suppress 
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that behavior. Lastly, an impairment that can be added as part of the dysexecutive 
“spectrum” is memory dysfunction: in PD patients this impairment does not affect 
directly the working memory itself, rather the problem resides more in attention defi-
cits and/or inefficient retrieval strategies of these memories. Retrieval, in particular, 
requires a conscious effort, a strategy, and it is this organizational aspect that the PD 
patient is inefficient at, with the result of appearing forgetful to family and caregiv-
ers. (Jankovic, 2002) 
The tests (see “Appendix 1” for some of current use), generally adopted for these 
reasons in clinical settings, are all evaluating the frontal lobe functions, in particular 
the formation of concepts, the individuation of implicit rules (“Wisconsin card sort-
ing” test and “Spatial delayed response” task), problem solving skills (“Tower 
Task”-like tests), the capacity of set shifting (“Trail making” and “Odd man out” 
tests) and, on the opposite, the ability to maintain a given mind set and therefore in-
hibiting interferences (“Verbal fluency” and “Stroop” tests). However, dysexecutive 
syndrome, as it is observed in PD, is a condition which can have different presenta-
tions, accordingly to the area of prefrontal cortex of major (or exclusive) affection. In 
particular, a major dorsolateral prefrontal cortex damage will cause the most severe 
cognitive deficits, while a major or exclusive disruption in the orbitofrontal cortex, 
having connections to the limbic region, will be reflected more as an impairment in 
the affective and social capacities. (Jankovic, 2002) 
3.7.5 Visuospatial impairments 
Despite clinical evidence (Tachibana, 2013; Aarsland, 2011) stated some connection 
between PD and visuospatial dysfunction, the main belief is that this impairment may 
be due primarily to the high cognitive demand that the tests used to ascertain it  re-
quires the patient: in these occasions, in fact, the patient is asked to perform tasks 
that also require a cognitive level that the syndrome may already make difficult to 
reach (for example, the capacity of centrally processing the various stimuli presented 
at the same time, or set shifting). Always in the field of visuospatial impairments, 
further impairments have been detected in the preattentive visual processing system, 
the unconscious collection of all the concomitant environmental stimuli destined to 
be filtered by importance by the brain. (Jankovic, 2002) 
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3.7.6 Behavioural deficits 
Mood and behavioral changes are often reported as features of PD: introversion, ob-
session with control of any life aspects, hypervigilance and caution, especially when 
finding himself in unusual situations, repression of strong emotions leading to apathy 
are the most commonly reported ones. Depression may also develop, together with 
and not as a consequence of the disease, since it is not strictly related to the stages of 
PD. However, the development of depression should require further attention, since 
evidence suggest this state may trigger, at first, attention and memory impairments, 
and then depressive mood can contribute to the development of dysexecutive syn-
drome. (Jankovic, 2002) 
3.7.7 Sleeping dysfunctions 
The disturbances in the sleeping REM phase, defined as “REM sleep behavior disor-
der” (RBD) have been already identified as one of the anticipating signs of a diagno-
sis of Parkinson’s disease, as well as other synucleinopathies. Other sleeping dys-
function, including insomnia and excessive drowsiness during the daytime are being 
investigated as other possible warning signs of a future diagnosis of Parkinson’s dis-
ease. (Manni, 2007) 
The REM sleep behavior disorder has also been observed to accompany PD through-
out its course, particularly those forms characterized by a quicker progression of the 
cognitive aspects, often into PD-specific dementia. In addition, RBD is associated 
with a significant likelihood of the patient presenting with concurrent visual halluci-
nations. Furthermore, the breathing pattern throughout the whole sleeping cycle, both 
REM and non REM phases, could result dysfunctional, with temporary, often period-
ical events such as sleeping apneas and/or hypopneas (this latter one indicating sig-
nificant reduction in the amplitude of the breathing pattern): this phenomena, defined 
as “Sleep Disordered Breathing” (SDB), have been shown to further make the patient 
prone to neuropsychological and cognitive impairments, including memory (both 
short and long term), logical functions and frontal activities. (Manni, 2007) 
22 
 
3.7.8 Sensory dysfunctions 
Parkinson’s disease patients may present either with hyposomia or anosomia. Olfac-
tory functions (smell detection, its source identification and the ability to discrimi-
nate one smell from the other) result impaired very early in the course of the disease, 
preceding by years the degeneration of the Substantia Nigra and the consequential 
motor signs and symptoms. (Antonini, 2012)  
Furthermore, the high recurrence at which this category of impairments occurs (at 
least 90%) makes it a significant contributor in differentiating idiopathic Parkinson’s 
disease patients from those suffering from other forms of parkinsonisms (Doty, 
2012).  
In the recent years, dysfunction of other sensory systems have been taken into con-
sideration in the ambit of Parkinson’s disease. Visual functions can result impaired in 
PD at different levels, either due to the increased risk of developing glaucomas, or as 
a consequence of the depletion of dopamine, which has been found to play a role in 
the organization of receptive fields and of the photoreceptors. These impairments can 
result in reduced visual acuity, in particular in contrast discrimination, colors recog-
nition, as well as abnormalities in the eye movement, as in smooth pursuit move-
ments, particularly along the vertical direction, together with a general reduction and 
jerkiness of eye movements; it has also been noted PD patients tend to exhibit a re-
duced blinking rate, this in turn contributing to the “expressionless” mask-face, to-
gether with dry eyes and generally a reduced vision; however, given the overlapping 
results between PD patients and healthy controls of the same age, further research is 
auspicable before considering them as possible biomarkers. (Armstrong, 2008) 
Hearing could be also involved in the evolution of this condition, as suggested by a 
study reporting a major frequency of hearing impairment in this category of patients 
when compared with healthy controls of the same age (Vitale, 2012). Studies con-
cerning this subject, though, are still limited in number, thus not providing yet a clear 
evidence on the possible link between Parkinson’s disease and hearing impairments.  
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3.8 Mild cognitive impairments anticipating dementia? 
These deficits will ultimately develop in dementia, though only a small percentage of 
the cases (about 25%) will be clinically recognized as such (Svenningsson, 2012).  
Despite the onset time of dementia can be extremely variable from one patient to the 
other (it can either be few years after Parkinson’s disease has been clinically diag-
nosed, to decades after), it has been observed that after dementia has sat in, the Par-
kinson’s syndrome will progress to its terminal stage in a typical average timing of 
three years. This being said, since early cognitive impairments can be the prodromes 
of dementia in Parkinson’s patients, it is important not only to establish better criteria 
to define mild cognitive impairments, but also to draw an optimal therapy that can 
enable the patient to at least slow down this decline. Exercise has drawn attention as 
a possible side effects-free way. (Svenningsson, 2012) 
3.9 Dementia in Parkinson’s disease 
As already stated, cognitive decline in Parkinson’s disease follows the motor symp-
toms (on the opposite, in Dementia with Lewy Bodies, the cognitive deficits pre-
cedes the motor ones) and with a rate which is slower in the earlier stages of the dis-
ease; nevertheless, once dementia sets in, the progression will follow a rather regular 
course: both physical and cognitive decline will progress into the terminal stage for 
about three years, with patient’s death. 
The time of onset of dementia can vary a lot: some patients will develop dementia 
few years after PD has been diagnosed, while for others it may take decades. 
It has been observed that a faster cognitive impairment (meaning a quicker develop-
ment into dementia) occurs:  
 in patients whose PD has been diagnosed in later age; 
 in patients whose motor symptoms are mostly of the non-tremor type (in par-
ticular relevant postural instability and disturbed gait); 
 in patients whose non-motor symptoms include hallucinations, behavioral and 
REM sleep phase disturbances and pronounced olfactory dysfunction.  
One of the challenges relies right in the difficulty of adopting clear and unified 
standards to define and diagnose mild cognitive impairment in PD: for this reason, 
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the Movement Disorder Society has been the first to propose the criteria that have 
received clinical consensus. (Litvan, 2011) 
4 EXERCISE IN PARKINSON’S DISEASE 
4.1 Aerobic exercise 
The definition of “Aerobic Exercise” applies to any intentional physical activity “us-
ing large muscle groups and maintained continuously with rhythmic pattern” 
(Hanson, 1988). 
Also, aerobic physical exercise can be differentiated in three main typologies; 
“Group 1” includes those physical activities which provide a constant bout of intensi-
ty - and the consequential energy consumption – independently from the individual’s 
skills in that very activity: examples of  “Group 1” activities would be brisk walking, 
cycling and even jogging. “Group 2” activities would be those which energy costs 
can register significant variations depending on the skills of the performer, as, for 
example, swimming or dancing. Wide variations in energy consumption from one 
performance to the other, instead, will be observed in those activities and sports such 
as football or tennis. (Kravitz & Vella, 2002) 
4.2 Low, medium or high intensity, what is better? 
Despite the studies carried out on this subject, the terminology concerning the physi-
cal exercise intensity level is still cause of imprecisions and misunderstandings; in 
order to provide the patients, especially those with limited experience in the sport 
field, a clear indication of the intensity of physical activity that would best suit their 
specific status, thus avoiding both under and over training, some standardization of 
the basic terminology for physical activity should be achieved.  
The basal metabolism, the minimum amount of energy an individual’s body requires 
in order to carry out its life functions in a physiological fashion is increased, at dif-
ferent levels, by any activity taken up by the subject; this increment occurs with any 
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activity of the living, from the very basic sleeping, up to the highest level of physical 
activity, that of the elite athletes. This increment in energy needs has been divided by 
Norton (2010) into five major ranges: sedentary, light, moderate, vigorous and high 
intensity. Activities can be classified into one of those categories according to either 
objective, subjective and descriptive measures. Objective measures are those ex-
pressed through METS (metabolic equivalents, 1 MET = 3,5ml O2/kg/min), HRmax 
(which can be either measured or more, quickly, though less precisely calculated 
with the formula: 220 – age), HRRmax (where HRR, heart rate reserve, is calculated: 
HRmax – HRrest), a safer threshold for calculating exercise intensity with less fit pa-
tients, or, finally, VO2max (which is the maximum quantity, volume, of oxygen con-
sumption, a very specific amount for each individual, not likely to change even with 
physical conditioning). Subjective measures, though less precise, are often used be-
cause considered more accessible to the patient, in particular when this is not so ac-
quainted with physical exercise. One form of subjective measurement is that provid-
ed by the use of the Borg RPE (Rated Perceived Exertion) scale: throughout it, the 
patient can indicate his level of fatigue, with 6 (zero) being the lowest level (corre-
sponding to the same fatigue that lying in bed would cause) and 20 being the highest 
(the same fatigue of a maximal, “all out” exercise) anytime during the activi-
ty/exercise session. Finally, the same “Position Statement” indicated a third category 
of measuring the level of exercise intensity, that of descriptive measures: these take 
into account some common reactions that can be observed at a given exercise intensi-
ty, like changes in breathing path, the capacity of maintaining the same intensity for 
1’ or less, the capacity to hold a conversation at the same time without running out of 
breath, etc). (Norton, 2010)  
Despite the arguable choice of selecting overlapping limits for all the objective 
measures, the following table summarizes in an efficient visual way the results of the 
review conducted by Norton and colleagues on the terminology and categorization of 
aerobic exercise adopted in the scientific literature. 
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Table 1. Categories of exercise intensity and the objective, subjective and descriptive measures ac-
companying each category. (Adapted from Norton, 2010)  
 
  
4.3 Effects of aerobic exercise on brain – how can aerobic exercise influence cogni-
tion?  
In these last decades many studies (Erickson, 2009; Bass, 2013) have been undertak-
en in order to assess the correlation between physical activity and cognitive func-
tions: across all the ages, from children to the elderly, healthy or already affected by 
cognitive dysfunctions (often age related), the results have proved this correlation to 
exist and to be particularly strong. 
What still have not been fully understood and documented is the causal relationship: 
how this beneficial documented effect of increased physical activity on specific areas 
of cognition is reached? Four main hypotheses have been individuated, these being: 
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cardiovascular, immunological, trophic factors (and their modulators) and fourthly, 
the neuroendocrine effect. (Phillips, 2014) 
4.3.1 Cardiovascular aspect 
Concerning the relationship between cardiovascular effects of increased physical ac-
tivity and cognitive functions, the improved hemodynamics, particularly that of those 
vessel supplying the brain area with oxygen and nutrients (and taking the “wastes” 
such as reactive oxygen species, or ROS, for example), consequential to higher levels 
of physical activity was associated with an inferior rate of gray and white matter loss. 
(Colcombe, 2003) 
All this evidence appears to be of particular strong relevance in the elderly popula-
tion (while the connection cardiovascular fitness improvement and cognition is not as 
clear cut in average, in the younger populations). (Lautenschlager, 2008) 
4.3.2 Immunological aspect 
The extent of the immunological effect will depend on the duration as well as the in-
tensity of the physical activity carried out by the individual; these beneficial effects 
will often include a general boost of immune function and increase in anti-
inflammatory factors. This immunological enhancement is fundamental, as evidence 
proved that inflammation, when reaches chronic levels can be a cofactor to neuro-
degenerative conditions (Parkinson’s disease included) as well as to cognitive im-
pairments. (Gleeson, 2011) 
4.3.3 Trophic factors action 
Neurotrophins are among the possible reasons explaining the beneficial effect physi-
cal activity can promote in terms of cognitive functions. Different polypeptides be-
long to the category of neurotrophins, and among these, the brain-derived neu-
rotrophic factor, or BDNF, is the most spread within the brain, particularly in the 
hippocampal region, which role is fundamental in learning and memory functions 
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(Phillips, 2014). Furthermore, BDNF retains a fundamental role in the survival of 
neurons, by influencing growth, differentiation and maintenance in general (Reich-
ardt, 2006). It has also been observed that BDNF is fundamental in preventing hip-
pocampal neuronal cells death and its plasma levels have proved to be a valid bi-
omarker when assessing memory impairments (Pringle, 1996; Komulainen, 2008). 
Evidence shows that physical activity, when in moderate intensity, is positively and 
significantly linked to raised BDNF serum levels, and this increase has been ob-
served to persist for up to seven days after the physical activity session. (Coelho, 
2014; Berchtold, 2005). However, the specific causes of this increment have not, so 
far, been clearly recognized. On the other hand, as scientific studies (Taverniers, 
2010) have shown, high intensity levels of physical exercise lead more to damages 
than benefits; this can occur in two ways: either by lowering the anti-oxidant factors 
count or by increasing the levels of the hormone cortisol. The brain, in fact, is re-
sponsible for at least the 20% of the whole oxygen consumption and this, together 
with brain low anti-oxidants levels already under physiological conditions, makes the 
central nervous system particularly vulnerable to the consequences of oxidative 
stress and their byproducts, as the so called “Reactive Oxygen Species” or ROS (Ut-
tara, 2009).  
5 STUDIES SELECTED 
5.1 Research history 
In June 2014 the search of studies for this thesis was carried out accessing PubMed 
database. An “advanced search” was chosen by inserting the terms "Parkinson’s” 
[Title/Abstract] AND "exercise" [Title/Abstract] AND "cognition” [Title/Abstract]. 
Search resulted in 17 articles. The following restrictions were applied at first: studies 
dating back to the last ten years, their subjects being “humans” and the studies being 
available in English and in free full text. Out of the initial 17 articles, 11 passed this 
first selection; then, the author reviewed all the abstracts of these 11 results in order 
to assess the ones that complied with the PICOS principles established beforehand 
and listed above: it resulted that four studies could be included in this thesis. In this 
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second phase of the search, reviews concerning the topic were excluded from the 
thesis material: however, these were kept into consideration as an eventual source of 
other articles that for any reason had been not included in PubMed. In an analogue 
fashion, Cochrane Library and PeDro databases were searched, leaving out of the 
results eventual duplicates, already included from the PubMed search. This being 
said, a total of seven studies had been selected for this thesis; these will be summa-
rized in the following paragraph. 
5.2 Studies included 
The seven studies selected have been collected in the following two tables. In the 
first table (Table 2), the type of study, PEDro rating, intervention and the different 
treatment plans administered in the sample and control group had been summed up. 
In the second one (Table 3), the modalities of assessment, the final results and the 
eventual causes of bias have been described. 
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Table 2. Intervention plan, PEDro grading, sample group and control group implementations. 
 
Title, Authors and Type 
of Study 
PEDro 
Grade 
Intervention Sample Group Control Group 
1) ”Benefits of physical 
exercise on executive 
functions in older people 
with Parkinson’s Dis-
ease”  
 
(Tanaka, 2009) 
 
Study 
 
 
 
 
 
 
 
 
7 Multimodal exercise program VS 
same daily routine. 
 
Participants qualified for the study 
when: 
•Clinical PD from 1 to 3 in Hoehn 
& Yahr scale. 
•No signs of dementia. 
•Haven’t taken part to any exercise 
program. 
•Attending min. 70% of the pro-
gram they are assigned to. 
5 women, 5 men. 
 
Multimodal exercise program for elder-
ly with PD: basic aerobics. 
60’ sessions, 3/week.  
The program consisted of six parts of 
increasing load, each made of 12 ses-
sions, lasting one month/each.  
 
Each session was divided in 5 parts 
(warm-up; pre-exercise stretching; ex-
ercise session; cool down; post exercise 
stretching). 
 
HR: 60-80% HRmax (only one partici-
pant/session had a HR monitor) 
6 women, 4 men; 
 
CG participated already as control group in another 
study in the same structure. 
 
This control group (CG) was asked to maintain the 
same daily routines, without joining any exercise 
program 
2) “Phase I/II random-
ized trial of aerobic ex-
ercise in Parkinson’s 
disease in a community 
setting”  
 
(Uc, 2014)  
 
6 Four different training methods:  
1_individual and continuous train-
ing; 
2_group continuous training; 
3_individual interval training; 
4_group interval training; 
The study was conducted throughout 
three years. 
 
Initially, during the first two years, 
participants were randomized into 4 
different training methods:  
1_individual and continuous training; 
2_group continuous training (only in 
No control group. 
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Randomized trial 
 
the first year); 
3_individual interval training; 
4_group interval training (only in the 
first year). 
 
Then, on the third year, the study fo-
cused only on continuous, individual 
training. 
3) “The effects of 
adapted tango on spatial 
cognition and disease 
severity in Parkinson’s 
disease” 
  
(McKee, 2013)  
 
Study 
 
 
7 • Adapted Argentinian Tango. 
• Patient education in the form of 
seminar. 
n pts = 24 
H&Y: I-III 
 
2x90 min./wk for a total of 20 sessions 
of adapted tango. 
 
Each class: 20’ standing warm up and 
practice of the steps already learnt; 
then new steps were added, strictly 
according to the manual, and after that 
those were integrated with the older 
ones.  
 
During the partnering phase, each pt 
both conducted and followed, though 
always paired with non PD partner. 
 
n pts = 9 
H&Y: I-III 
 
2x90 min./wk educational sessions for a total of 20 
sessions.  
 
Health-related topics with medical students and 
professors. 1hr+30’ discussion. 
 
4) “Exercise and Parkin-
son’s: benefits for cogni-
tion and quality of life” 
 
(Cruise, 2011) 
 
Study 
4 • Exercise Intervention Program 
(EIP, n=15) 
• Control group (n=13) 
n pts =15, 
2/wk for 12 wks. 
 
Each session (60’) always included 
both aerobic and strength training. 
Each session included:  
• 5’ warm up (low intensity aerobic 
activity such as walking, stationary 
cycling and stretching). 
• Resistance training: 6 exercises for 
n pts =13,  
maintained its usual lifestyle for 2/wk for 12 wks. 
 
Baseline and follow-ups carried out always during 
the “on” phase. 
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both upper and lower body major 
groups. 
• 25-30’ aerobic training: stationary 
cycling, rowing, treadmill at 60-85% 
HRmax. 
 
The intensity of the exercises was in-
creased gradually throughout the ses-
sions. 
5) “Can exercise im-
prove language and cog-
nition in Parkinson’s 
disease? A case report”  
 
(Nocera, 2010) 
 
Single Case Report 
(4)* 8 weeks of aerobic exercise as sin-
gle and dual task. 
 
Intensity: starting from 50% 
HRRmax, increased by 5% every 
week up to 75% HRRmax. 
Subject of the study: woman  
idiopathic PD for 11yrs 
66 y.o.  
H&Y: 2 
UPDRS: 31/106 
dx-handed 
 
Aerobic Exercise in the form of sta-
tionary ergometer in single and cogni-
tive dual task. 
 
Therapy delivered for 8 wks, 
3times/wk, for a duration of 20’ each. 
No control group 
6) “Efficacy of a multi-
modal cognitive reha-
bilitation including psy-
chomotor and endurance 
training in Parkinson’s 
disease”  
 
(Reuter, 2012) 
 
Clinical Study 
8 Random allocation to group A, B 
or C, (C being the “sample group”) 
with different combination of cog-
nitive, transfer, psychomotor train-
ing, plus occupational therapy and 
relaxation sessions to reach the 
same amount of therapeutic inter-
ventions in each group. 
 
The study was structured in 2 
phases: 
Period 1: 4wks, at the rehabilitation 
unit. Physiotherapists, occupational 
240 pts 
 
male and female 
 
Age:  50-80 y.o. (average 64±4 yrs) 
 
Diagnosed w/ PD 
(average diagnosed 8 before) 
 
Mild Cognitive Impairment (MCI) in-
clusion criteria 
 
Patients did not differ demographically 
Two control groups, group A and group B. 
 
Group A: 
exclusive cognitive training 
(plus to reach same amount of training time of 
group C,  relaxation and occupational training) 
 
Group B: 
cognitive training, 
transfer training 
(Plus to reach same amount of training time of 
group C, relaxation and occupational training). 
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therapists and neuropsychologists. 
Period2:  6mo, with fami-
ly/caregiver collaboration (after 
receiving education), training pro-
grammes adapted to individual 
home settings. 
 
More specifically: 
COGNITIVE TRAINING: 
• 60’ lessons 
• 4 times/wk 
• individual sessions 
• min. 14 sessions/pt 
• cognitive program individually 
tailored on pt’s needs. 
 
TRANSFER TRAINING:  
• ADLs in different settings,  
• 3 times/wk,  
• total 10 sessions 
• 90’duration each. 
 
MOTOR TRAINING: 
• 60’ sessions 
• 10-12 sessions 
• games and tasks (e.g. orienta-
tion); 
• dual tasks (walk and bounce or 
throw a ball); 
• parcours w/obstacles; 
• Aerobic activities including 
treadmill walking in winter and 
Nordic walking in summer 
• during the 2nd phase at home, 
caregiver received instructions how 
from one group to the other. 
 
Group C: 
cognitive training, 
transfer training, 
psychomotor training. 
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to organize the sessions, so that 
40% outdoor and 60% gym 
 
All the training programs were 
carried out having the patients in 
the “on” stage. 
 
7) ”Intensive Rehabilita-
tion Increases BDNF 
Serum Levels in Parkin-
sonian Patients: a Ran-
domized Study”  
 
(Frazzitta, 2014) 
 
Randomized Study 
9 SUBJECTS: 
• Average age 67±5 
• Idiopathic PD. similar duration 
(approx. 8 yrs) 
• H&Y 1-1,5. 
• Rasagiline treatment. 
• No other neurological comorbidi-
ty. 
• Mini mental state examination 
>26. 
• Vision and hearing sufficient to 
understand the instructions. 
• Walking w/out physical assis-
tance. 
 
METHODS: 
• 2 groups, treatment group and 
non-treatment/control group. 
• 4 weeks therapy. 
• 3 daily sessions (2 in the morn-
ing, 1 in the afternoon).  
• 1 hour duration/session. 
• 5 days/week. 
• 3 session/day, 1 hour each. 
 
SESSION 1: 
Cardiovascular warm up, ROM spinal, 
pelvic and scapular joints, strengthen-
ing abdominal wall, postural changes 
from supine, stretching, relax. 
 
SESSION 2: 
• balance training on stabilometric plat-
form + visual cue;  
• gait training on treadmill plus (visual 
and auditory cue), HRreserve ≥60% for 
30’every day for 4wks. 
 
SESSION 3: 
Occupational therapy for ADL: trans-
fers, rolling in bed, dressing, tool us-
age, hand skills. 
No treatment. 
(*) = This article, being a single case report, is not particularly suitable to be graded according to the PEDro scale. 
 
 
Table 3. Assessment tests, study results and eventual reasons of bias. 
36 
 
 
Study  
(Title, Authors and 
Year ) 
Assessment Results Bias/Discussion 
1) ”Benefits of phys-
ical exercise on ex-
ecutive functions in 
older people with 
Parkinson’s Disease”  
 
(Tanaka, 2009) 
• Wisconsin card sorting test (execu-
tive functions). 
 
• Wechsler adult intelligence scale III 
(concentrated attention). 
 
• State trait anxiety inventory (anxie-
ty). 
 
• Hospital anxiety and depression 
scale (depressive symptoms, not the 
anxiety part) 
As shown by the Wisconsin card sorting test, the 
study group improved in the executive functions, 
particularly in the variables:  
 “Categories completed” (telling about the abil-
ity to concentrate on specific aspect and ignore 
others) 
 “Perseverative errors” (index of mental flexi-
bility). This was not the case of the control 
group.  
 
Both the groups showed no significant improve-
ment in the “Confounding variables” (concentrated 
attention, state anxiety and depressive symptoms) = 
the improvement in the Executive Functions regis-
tered in the sample group was not due to a change 
in confounding variables, but strictly to the exercise 
regimen. 
 
I. Procedure was not purely random. 
 
II. Not enough HR monitors for the control group 
sessions. 
 
III. Although further explanation of the exercise 
sessions is available in the article, still the very 
exercises instructed are not illustrated. 
2) “Phase I/II ran-
domized trial of aer-
obic exercise in Par-
kinson’s disease in a 
community setting”  
 
(Uc, 2014)  
• Eriksen flanker task (primary cogni-
tive measurement) 
• Stroop test (inhibition of secondary 
stimuli). 
• Wisconsin Card Sorting test (set 
shifting). 
• Trail making test (set shifting). 
• Judgement of line orientation (visual 
perception). 
• Complex figure test-copy (visual 
perception). 
• Rey auditory verbal learning test 
(verbal memory). 
Improvements in different categories have been 
reported: 
1. Aerobic fitness and motor function; 
 
2. Cognition (flanker test); 
 
3. Quality of life and other non-motor functions. 
 
Concerning cognitive improvements, those were 
mostly in the area of inhibition (selective cognitive 
improvement). 
I. NO control group: efficacy of the implementa-
tion cannot be proven; still, the authors claimed 
that this phase of their on-going study provided 
indications more on safety, tolerability and gen-
eral feasibility for a future phase three of this 
study. 
 
II. The study design was partially modified 
throughout the years, in particular: 
 “Group setting”: no randomization was pos-
sible, due to logistical factors (rural residence 
of the patients); for this reason, the “group 
setting” was abandoned after the first year of 
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• Complex figure test-recall (visual 
memory). 
• Controlled oral word association test 
(language). 
• Montreal cognitive assessment 
(general cognition). 
• Geriatric depression scale (depres-
sion). 
• PD quality of life scale PDQUALIF 
(quality of life) 
study. 
 “Interval exercise modality”: abandoned as 
well in the third year, due to safety issues. 
3) “The effects of 
adapted tango on 
spatial cognition and 
disease severity in 
Parkinson’s disease”  
 
(McKee,  
2013) 
• MoCA - Montreal Cognitive As-
sessment (general cognition). 
• Reverse Corsi Blocks (visuospatial 
memory). 
• Brooks Spatial Task (spatial cogni-
tion).  
• UPDRS-III 
• FAB - Fullertorn Advanced Balance 
Scale.  
• Four-Square Step Test. 
• TUG – Time Up and Go (single 
task, dual cognitive task and dual 
manual task). 
• PDQ-39 – PD Questionnaire 39. 
• FOGQ – Freezing of Gait Question-
naire. 
• Short Form Health Survey-12 (phys-
ical PCS and mental composite 
MCS). 
The adapted tango intervention was found to en-
hance cognition, mainly evidenced in the MoCA 
test. 
 
A positive trend has been observed also in the Re-
verse Corsi Blocks test. 
 
These results were maintained at the 12th week 
follow up. 
 
Other main results included the improvements re-
ported in the tango group in the FAB and the Four-
Square Step tests.  
 
These results were maintained in the postop. 
 
No main effects were reported concerning the TUG. 
I. Small sample size (particularly the control 
group). 
 
II. Slight age difference between the two groups. 
 
III. Participants knew their group assignment. 
 
IV. Some raters were not blinded. 
 
V. Treatments administered in two different cen-
ters. 
 
VI. Education group began one week earlier. 
 
VII. Places for the control group were filled be-
fore passing to the tango group. 
 
VIII. Participants took part to the interventions 
only when in “on” phase. 
 
IX. No distinction made between dx and sin. side 
dominant disease. 
4) “Exercise and 
Parkinson’s: bene-
fits for cognition and 
• Verbal Fluency (words starting with 
F, A and S for 1’ each). 
 
Concerning the neuropsychological results, a 10% 
change has been considered to be clinically mean-
ingful.  
I. Small sample (28 individuals completed the 
study). 
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quality of life” 
 
(Cruise, 2011)  
• Semantic Fluency (for animals in 1’ 
period). 
 
• Pattern Recognition Memory test. 
 
• Spatial Recognition Memory test. 
 
• Spatial Working Memory test. 
 
• Stockings of Cambridge (working 
memory and spatial planning). 
 
• Geriatric Depression Scale (GDS – 
level of depressed mood). 
 
• Parkinson’s Disease Questionnaire 
(PDQ-39). 
This said, the conclusions were: 
 
• Exercise is “likely beneficial” for improving ver-
bal fluency and spatial working memory (SWM). 
 
• Exercise is “possibly beneficial” for semantic flu-
ency for animals. 
 
• Both EIP and control had conditions “possibly 
beneficial” for the Stockings of Cambridge. 
 
• No clinical benefits came from pattern/spatial 
recognition (neither for EIP and control groups). 
 
• Exercise was reported not to have any negative 
effect. 
II. Participants’ depression level was in the nor-
mal ranges and none of the pts reported poor dis-
ease-specific QoL at the beginning of the study: 
this could have affected the post intervention rela-
tive measurements. 
 
III. Participants selected only from support 
groups: these may be more self-motivated and 
active at looking for support than other parkin-
sonians. 
 
IV. Treatment of the control group: some benefits 
in the EIP could be due more to social interaction 
than to the exercise intervention itself. 
5) “Can exercise 
improve language 
and cognition in Par-
kinson’s disease? A 
case re-port”  
 
(Nocera, 2010)  
Only single task: 
• Mini-Mental Status Examination. 
• Stroop test (color X’s and color 
words). 
 
Both single and dual task: 
• Verbal fluency-animals. 
• Verbal fluency-letters (F; A; S). 
• Digit span forward and backward. 
• Picture description task (language 
function). 
 
Major improvements were observed in: 
 
 Stroop Color X’s test; 
 
 Stroop Color Words; 
 
 Verbal Fluency-Animals (single task). 
 
 Only a minimal improvement was seen in Ver-
bal Fluency- Letters. 
 
 “Picture Description”: improvements in con-
ciseness, grammar and contained less extrane-
ous comments. 
 
I. The motor tasks for assessment and training 
were the same: difficult to distinguish the im-
provement due to practice of the task and those 
due to cognitive improvement. 
 
II. One case only under study, low representative-
ness.  
 
III. Lack of a control group as comparison. 
6) “Efficacy of a 
multimodal cognitive 
rehabilitation includ-
Blinded assessors. 
Assessment Tests: 
• UPDRS 
Neuropsychological assessment: at screening ses-
sion, no differences between the groups, all of them 
with deficits particularly in the EF.  
Motor Training: 
Pts had difficulties solve some tasks by them-
selves, e.g parcours with obstacles; it was not 
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ing psycho-motor 
and endurance train-
ing in Parkinson’s 
dis-ease”  
 
(Reuter, 2012) 
• GAS 
 
The following tests were administrat-
ed at the beginning (baseline), after 
4wks of the “period 1” (second as-
sessment) and 6mo later, at the end of 
“period 2” of the study (final assess-
ment): 
• PANDA 
• MMSE 
• ADAS-COG 
• SCOPA-COG 
 
As for health-related QoL: 
• PDQ-39 
 
Additional tests for Executive Func-
tion (baseline, second assessment, 
final assessment):  
 
• PASAT-Paced Auditory Serial Ad-
dition Test (processing information 
speed). 
 
• BADS-Behavioral Assessment of 
the Dysexecutive Syndrome. 
 
•MWT-B (Mehrfach-Wortschatz-
Test) for premorbid performance. 
 
• Multiple choice word test. 
 
• Hospital anxiety and depression 
scale. 
 
EF-BADS scale, did not differ at the baseline. The 
difference was relevant after period 1 (p<0,03) and 
at the final assessment (p<0,01). An even more 
significant difference of improvement between 
sample group and the control ones was observed (p 
0,001 at the final assessment). Also, only the group 
C maintained the levels of improvement after the 6 
months. 
 
PASAT Test: only group B and C showed im-
provements. 
 
GAS scale is indicative as well. When, at the last 
assessment, the goals were reviewed to check 
whether they had been reached, subject from the C 
group showed a major tendency to meet their objec-
tive (p<0,001). The goals did not differ particularly 
from one group to the other, gravitating all around 
the spectrum of EF. 
 
PDQ-39. Group C tended to rate their QoL higher 
than the controls, while the UPDRS showed at the 
final assessment a mild improvement in all the 
groups (meaning that the reported selective cogni-
tive improvement in EF is not only part of a general 
benefit of the therapy to the whole condition). 
 
possible to hold group lessons. 
 
I. Three different treatments combinations were 
under study, no real “control” group (“No treat-
ment”). 
 
II. No evidence based for what transfer-exercises 
are the most effective: the selection of the exer-
cises used in this section is based only on thera-
pists’ and medical staff’s. 
 
III. ADAS-COG and SCOPA-COG may be con-
sidered not clinically relevant. 
 
IV. Short follow up, only 6 months (long term 
effects from the different exercise regimes cannot 
be reported). 
 
V. Physical exercise was paired with other modal-
ities of exercise: not possible to completely iso-
late the benefit coming from the first exclusively. 
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7) ”Intensive Reha-
bilitation Increases 
BDNF Se-rum Lev-
els in Parkinsonian 
Patients: a Random-
ized Study”  
 
(Frazzitta, 2014) 
• Blind assessors and observer. 
 
• Measurements could be taken in 4 
occasions: 
T0 = baseline 
T1 = 10 days after 
T2 = 20 days after 
T3 = 28 days after 
 
Primary outcomes were serum BDNF 
and UPDRS III, assessed in both 
groups. 
 
UPDRS II, UPDRS tot, BERG bal-
ance scale, 6MWT only in the treat-
ment group. 
The sample group showed improvements in motor 
factors (balance and gait). 
 
The sample group also showed significant and per-
sistent increases in serum BDNF levels (average 
increment of 14%), whose role has been proved be 
fundamental in cognitive functions. 
I. Group tested relatively small. 
 
II. Durability of the results unknown. 
 
III. Eventual correlation BDNF serum levels and 
motor performance not established. 
 
IV. Efficacy, feasibility and costs of the treatment 
of the study should be assessed outside the clini-
cal settings, before establishing eventual validity. 
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6 CONCLUSIONS FROM STUDIES REVIEWED 
 
What this review put into evidence, as well as other studies in the previous years did, 
is that the endurance/aerobic type of physical activity may be beneficial  to the dif-
ferent cognitive functions of individuals suffering from PD; moreover, there are add-
ed benefits when the intensity of the exercise rises to medium or medium-high. More 
in particular, the aspects of cognition which have been seen to benefit (either by 
means of maintenance or, more often, enhancement of a specific cognitive domain) 
of the new aerobic regimes are: concentration (or the ability to sustain attention on a 
given stimulus), inhibition of unnecessary stimuli, mental flexibility (or the ability to 
shift the attention from one stimulus to the other), visuospatial memory, verbal flu-
ency (more for semantic animal, minimal for letters) and velocity of processing the 
available information and stimuli.  
Furthermore, Frazzitta (2014) reported a significant increase in the serum BDNF, 
which has been proved to act on the growth and/or maintenance of neural brain cells 
(particularly of the hippocampus) and, consequently, be a relevant contributor of the 
cognitive functions.  
However, being the cognition itself a term underlying more than one specific func-
tion, the studies which, so far, had been carried out on this subject have been focus-
ing on, and addressing  the assessment batteries to, one or more of these subcatego-
ries, inevitably ignoring others. This being said, any comparison of one study to an-
other, though all belonging to the same area of the interventions addressed to the 
cognitive deficits in Parkinson’s disease, should be done taking into account their 
efficacy had been evidence proven strictly regarding some of the cognitive demands. 
Therefore, in order to determine an eventual most effective form of aerobic physical 
activity, the author believes future studies should take into consideration, and destine 
an appropriate assessment measurement, to each and every feature of cognition. 
The duration of the interventions were variable, both if considering the overall extent 
of the studies, ranging from a minimum of four weeks to the maximum of three 
years, but also regarding that of the single sessions, from a minimum of 20 minutes 
to a maximum of 90 minutes. The frequency of the implementations varied from 
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twice a week up to everyday sessions; also, the same study which required daily ses-
sions was the only one having them divided in three parts throughout the day, ac-
cordingly to the modalities of the activity.  
However, although all these studies give a hint of eventual potential benefits that 
physical activity, specifically the aerobic one, retains on the cognitive functions of 
individuals suffering from Parkinson’s disease in the mild stages, not all of them in-
dicated, explicitly, a description and specific dosage of the activities taken into con-
sideration. Synthesizing the whole activity with the name of “cardiovascular” or 
“aerobic” exercise contributes to make these studies difficult to be compared to one 
another and to be evaluated in terms of time spent, intensity and outcomes; the same 
lack of specificity make it difficult to actually assess what could be, if possible, the 
best option available. In addition, the same vagueness renders the studies interested 
of little use from the perspective of making the results more easily accessible by the 
population not belonging to the specialized field: Parkinson’s disease patients in first 
person, their caregivers, but also those individuals interested in taking the available 
preventive actions as they age.   
7 DISCUSSION 
The topic of this thesis was chosen by the author consequently to a personal interest 
that rose in the context of a clinical placement in a neurological ward. However, 
what was the original idea of systematic review following the PRISMA statement 
(Website of the PRISMA Statement) could only be followed partially and the meta-
analysis was not feasible, given the lack of formation and experience of the author in 
this specific area of research: this would have probably addressed the set questions 
more accurately. Furthermore, the restricted amount of time, this being necessary to 
present this thesis in the agreed amount of time, and the fact that the author was car-
rying out this review by herself also acted as limiting factor to the possibility to ac-
quire the necessary skills right in advance, before starting writing the review. A fur-
ther limitation was that, once the results were retrieved and visualized from the dif-
ferent search engines, only those articles, the visualization of those required either no 
charge or a minimum one (inferior to ten euros), were taken into consideration when 
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selecting the studies to be included in the review. This condition, summed to the fact 
that, originally, only few articles matched the requirements of this review, deter-
mined the small number of articles selected (seven). In order to provide a spectrum 
as wide as possible of alternative forms of aerobic physical activity, which, at the 
same time, had been proven to be accessible to those individuals diagnosed with Par-
kinson’s disease from a mild to a moderate stage, different types of study design 
were included in the review: even when they were not paired with a control group, 
what the author retained of main importance was providing a “compendium” of what 
the available alternatives are, in terms of aerobic exercise and concerning this very 
specific class of subjects. This being said, it can be easily argued that the quality lev-
el of the different studies taken into account may be varying, when voices, such as 
the presence of any control group, or the methods of randomization adopted through-
out the course of the study, are found to be not completely satisfactory, when com-
pared to the highest standards auspicated by the instructions for systematic reviews; 
nevertheless, as already stated, it must be taken into account that the main objective 
of this thesis was that of providing multiple options of exercise to any eventual Par-
kinson’s disease patient, falling into the first three stages of the disease, who is will-
ing to actively take charge, at least in part, of his/her condition also from the cogni-
tive perspective. 
Coming to the studies themselves, the variety of implementation modalities, as well 
as the different outcome measures, made the possibility of a reliable comparison be-
tween one study and the other rather unlikely, since this would require, to begin with, 
dealing with the same variants (for example the same activity and assessment test) in 
each and every study. It should be noticed, however, that any of these studies was 
reported to be beneficial for at least one of the dominions of cognition: this, in the 
author’s opinion, is indicative of the fact that, although it may still not be possible to 
determine the optimal exercise regime when it comes to protecting and enhancing the 
cognitive functions of individuals affected by mild to moderate Parkinson’s Disease, 
any of the offered modalities of aerobic physical activity, perhaps together with new 
proposals, could potentially be the best solution in this clinical context, provided that 
all the cognitive areas have been assessed and the results compared with those of the 
other modalities. 
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 APPENDIX 1 
TESTS GENERALLY EMPLOYED TO ASSESS DYSEXECUTIVE SYNDROME  
 
Wisconsin Card Sorting Test (Wcst) 
 
During this test, the stimuli are given to the patient in the form of cards (see picture 
3), all of them presenting some colored shapes on them. The cards are differentiated 
by shape, color and quantity of shapes pictured on each of them.  
 
Picture 3. Example of WCST (source: http://en.wikipedia.org). 
The participant to the test is asked to sort the cards into piles (the number of piles can 
variate from one version to the other of this test) according to some principle. The 
participant, though, is not told what principle is the correct one: the requirement of 
the test is for the participant to guess it out, with the only indications given from the 
test administer being whether each trial of the patient follows or not the chosen prin-
ciple. Moreover, throughout the test, the sorting principle will be changed, unbe-
knownst to the patient, and the test taker will have to discover the new rules as well, 
in order to pass the test. 
 
 
Spatial Delayed Response Task (Sdr) 
 
This test assesses the patient’s spatial working memory. The patient is asked to look 
at a monitor and focus on the fixation point; while the test taker is still looking at the 
fixation point, another one, a cue, appears for milliseconds in another position to-
wards the edge of the screen (32 locations are possible). Then, a delay interval is then 
 imposed, showing only the fixation point at the center of the screen (during this in-
terval, different geometrical shapes can be shown in place of the original one: in this 
case the patient, in order to prosecute to the next phase, is asked to press the spacebar 
of the computer only when a diamond shape will appear as fixation point). In the fol-
lowing phase, the participant must indicate where the cue had appeared on the 
screen. (http://www.cognitiveatlas.org/) 
  
Picture 4. Example of SDR, no-distractor and one-distractor trial (source: http://jn.physiology.org). 
 
 
Tower of London test (and variations) 
 
Tower of London is a version of the traditional puzzle Tower of Hanoi; different ver-
sions of this test have been developed, both manual and multimedial. The Tower of 
London is a tool to evaluate the problem-solving capacities of an individual. More 
specifically, it assesses the planning capacities, fundamental in order to accomplish 
everyday tasks, which may result impaired by different neurological conditions, in-
cluding Parkinson’s disease. The patient is first showed a model where beads of dif-
ferent colors and/or dimensions (depending of the version of this test) are inserted on 
two or more rods. The testee is then asked to rearrange the beads of his/her station 
(see picture 5) from the starting position in order to match the position of the beads 
in the model, this following some rules he/she has been made aware of beforehand 
(e.g. smaller and light colored beads cannot be placed below bigger or darker colored 
ones) . (Tower of London – Sanzen Neuropsychological Assessment Tests LLC, 
2012 https://neuropsychological-assessment-
 tests.com/sites/default/files/Tower%20of%20London%20Manual.pdf ) 
 
Picture 5. Example of Tower of London Stations (reference: http://cbs-
neuromarketing.wikispaces.com/Decision+making) 
 
 
Trail Making Test 
 
It is a neuropsychological test of visual attention and task switching. Trail making 
test is made up of two parts, A and B, in which the patient is asked to connect a set of 
25 dots as fast as possible, but, at the same time, maintaining the accuracy necessary 
to keep the pen, or pencil, in contact with the surface of the paper. The test can be 
administered either by paper or on a computer; the test is divided into two phases, A 
and B: in both of them, the patient is instructed to connect with a line 25 dots, but, 
while in the A-phase the targets are all numbers, to be ordered from 1 to 25, in the B-
phase, the patient has to alternate between numbers and letters of the alphabet, both 
to be ordered in a crescent way (e.g.: 1, A, 2, B, 3, C,..)(see picture 6); in case the 
testee commits a mistake, the tester is entitled to correct him/her before passing to 
the next dot. The goal of the test is to complete the whole test, parts A and B, as 
quickly as possible; eventual mistakes in the tracking will not be taken into account 
in the paper version of the task, also due to the fact that these errors would anyway 
have an influence on the time of completion of the task. The main scores are given 
by measuring in seconds how much time will it take for the patient to complete each 
phase of the test (therefore giving two different times, usually the one relative to the 
 B-phase being longer, due to the more complex nature of this part of the test); While 
part A of this test mostly measures the processing speed of the individual, part B 
takes into account also the executive capacity of the testee; visual search and mental 
flexibility are considered to be involved as well in the completion of Trail Making 
Test. (Tombaugh, 2004) 
 Picture 5. Example of phase B of Trail Making Test 
(source: http://doa.alaska.gov/dmv/akol/pdfs/uiowa_trailmaking.pdf ) 
 
 
Odd Man Out Test  
 
The Odd Man Out is a test measuring a subject’s reaction time in telling, given three 
stimuli, which one between the first and the second is the furthest from the second, 
central one. The “Odd man out” will then be the stimulus recognized to be the more 
distant from the central, second, stimulus.  (Diascro & Brody, 1994). One version 
commonly used is the one making use of an adaptation of the so called “Jensen 
Box”, with three lights being turned on at each trial and the patient being required to 
sort out the furthest light as the Odd Man Out stimulus. (Mackintosh, 2011). The 
main outcome that this test assess is the speed of the subject to understand the even-
tual relationships existing among different stimuli; it is, moreover a tool to assess the 
ability of the individual to process a given information, in particular the speed of in-
spection and the subsequent making of an appropriate decision. (Mackintosh, 2011) 
 
 
 Verbal Fluency Test  
 
In the verbal fluency test, the patient is asked to list as many words as possible of a 
given category (established beforehand by the tester) within a given amount of time 
(usually 60 seconds). The category can either be semantic (e.g. animals, food…) or 
phonemic (e.g. words beginning with a given letter). (Lezak, 1995). Although the 
main outcome is  the total number of words told by the testee, other important infor-
mation can be drawn by taking into consideration eventual repeated words, the words 
belonging to a same subcategory (“clustering”), their number and length, as well as 
the number of switches to other subcategories (“cluster switching”). (Tombaugh, 
2004). Throughout studies based on voxel-based lesion symptom maps it has been 
evidenced that the deficits in semantic and phonemic fluency are originated by le-
sions in different brain areas, more precisely in the temporal and frontal cortices, re-
spectively. (Baldo, 2006). 
 
 
Stroop Test  
 
Also called the “Stroop color word test”, it is a neuropsychological test measuring 
the ability to set shift and ignore/repress, as quickly as possible, the interfering in-
formation, which are of no use for the completion of the task proposed. Based on the 
effect described by the American neurologist John Ridley Stroop back in 1935, this 
test can be administered in many versions, each including some subtasks; one of the 
most common is divided in three subparts: the first one, “Word-task” requires the 
patient to simply read a set of words indicating colors; then, in the second part, the 
“Color-task”, the subject will have to tell the color of a series of “Xs”; finally, as 
third task, the “Color-Word-task” consists of a panel on which the names of different 
colors have been written in different inks, which, however do not match with the 
name of the color indicated (Picture 7). The patient is then asked to name the color of 
the ink the word is written it. As already mentioned, further different variants of this 
test are available, their main difference being the number and type of subtasks. Simi-
larly, the score can be calculated either as the number of words read in a given 
amount of time, or as the amount of time necessary to carry over the single subparts 
as well as the whole task. (Homack, 2004). 
   
Picture 7. Example of Stroop Test panel (source: https://faculty.washington.edu/chudler/sout2.html ). 
 
 
Eriksen Flanker Task 
 
The Eriksen Flanker Task is a test employed to assess the ability of a subject to in-
hibit unnecessary stimuli presented in a given situation. Diverse studies had proven 
that the response to a stimulus tends to be slower when distracting items are present-
ed together with the stimulus: this observation applies to the whole population and 
has been seen to persist even in the case the testee is aware he/she has to ignore those 
extra stimuli (Davelaar, 2013). Although this test may present in some variants, the 
very basic idea is that of presenting the testee with a central stimulus, that has been 
put next to secondary stimuli and to which he/she will have to give an appropriate 
response to; these secondary, non-target stimuli can be of three different types: they 
can be “congruent”, meaning they trigger the same response of the central, target 
stimulus and can even present identical to this last one in shape; the non-target object 
can be “incongruent”, prompting a response in the subject that would be the opposite 
of the one associated with the central stimulus; third and last, the flanking stimuli can 
be of a “neutral” type, generating neither the same, nor the opposite response of the 
one triggered by the target stimulus. (Davelaar, 2009) 
Originally, in the 1974 version of this test, the stimuli were constituted by letters, 
usually grouped in batches of seven items, then, later on, other variants were intro-
duced, presenting arrows, numbers, colors and even setting the stimuli along direc-
tions other than the horizontal one. This being said, examples of incongruent stimu-
lus could be HHHSHHH or >>><>>>, while congruent ones could be CCCCCCC or 
>>>>>>>. An example of neutral stimulus would be, instead □□□>□□□, where target 
and secondary signals do not belong to the same category and, thus, are not compa-
rable to one another. (Lamers, 2011). Despite this test is administered with the inten-
tion to assess the ability of a subject to respond to a central stimulus meanwhile in-
hibiting the coexisting unnecessary ones, still no clear explanation has been formu-
 lated concerning how an individual manages to operate the selection between the tar-
get and unnecessary stimuli (Davelaar, 2013).  
 
 
Montreal Cognitive Assessment 
 
The Montreal Cognitive Assessment, or MoCA, was developed with the purpose of 
promptly recognize those individuals exhibiting “signs” of a possible mild cognitive 
decline in both physiological and pathological aging settings. It is considered a quick 
assessment tool since it allows, in approximately ten minutes, to screen different are-
as of cognition, also given the fact that the tasks making up the test may be indicative 
of more than one domain (Picture 8). 
Executive functions are assessed in three parts: first, through a modified version of 
the B-phase of the “Trail making test”, then with a “Letter fluency test” and thirdly, 
using an abstraction task, requiring, for instance, to find out the similarities between 
two given items. Visuospatial skills are assessed with two tasks, the first one requir-
ing to draw a clock indicating a given time, the second implying the copy drawing of 
a tridimensional cube  (Nasreddine, 2010). Other domains of cognition which are 
being assessed throughout this test are attention, concentration, memory, language, 
conceptual thinking, calculations, and orientation. 
Although the maximum score is 30, reaching 26 points is considered enough for av-
erage, healthy subjects; furthermore, according to the official website, a score from 
18 to 26 indicate a mild cognitive impairment, one from 10 to 17 a moderate cogni-
tive impairment while less than 10 suggests a severe cognitive impairment. It should 
be kept into consideration, however, that this division of the scorings is not officially 
set yet, as the official MoCA webpage states (Nasreddine, 2003). 
  
Picture 8. Example of Montreal Cognitive Assessment test (source: www.mocatest.org). 
 
 
  
 APPENDIX 2 
ARTICLES GRADING ACCORDING TO PEDro SCALING SYSTEM 
 
The author of this thesis used the PEDro scale system in order to give an indication 
of the methodological quality (more precisely, the “internal validity” and the “gener-
alizability”) of the studies that had been included in this work 
(http://www.pedro.org.au/english/faq/). However, although a useful instrument, it 
should not be considered a measurement toll measuring the absolute validity of a 
study, as the same PEDro website suggests. 
 
PEDro Scale items 1) 2) 3) 4) 5)* 6) 7) 
1. Eligibility criteria were specified. yes yes yes yes yes yes yes 
2. Subjects were randomly allocated to groups 
(in a crossover study, subjects were randomly 
allocated an order in which treatments were 
received). 
no no no no no yes yes 
3. Allocation was concealed. no no no no no no yes 
4. The groups were similar at baseline regard-
ing the most important prognostic indicators. 
yes yes yes yes no yes yes 
5. There was blinding of all subjects. no no no no no no no 
6. There was blinding of all therapists who 
administered the therapy. 
no no no no no no no 
7. There was blinding of all assessors who 
measured at least one key outcome. 
yes yes yes no no yes yes 
8. Measures of at least one key outcome were 
obtained from more than 85% of the subjects 
initially allocated to groups. 
yes yes yes no yes yes yes 
9. All subjects for whom outcome measures 
were available received the treatment or con-
trol condition as allocated or, where this was 
not the case, data for at least one key outcome 
was analyzed by “intention to treat”. 
yes no yes no yes yes yes 
 10. The results of between-group statistical 
comparisons are reported for at least one key 
outcome. 
yes yes yes yes no yes yes 
11. The study provides both point measures 
and measures of variability for at least one 
key outcome. 
yes yes yes yes yes yes yes 
TOTAL SCORE 7 6 7 4 4* 8 9 
 
(*) = This article, being a single case report, is not particularly suitable to be graded 
according to the PEDro scale. 
 
Where: 
1)”Benefits of physical exercise on executive functions in older people with Parkin-
son’s Disease” (Tanaka, 2009). 
2) “Phase I/II randomized trial of aerobic exercise in Parkinson’s disease in a com-
munity setting” (Uc, 2014). 
3) “The effects of adapted tango on spatial cognition and disease severity in Parkin-
son’s disease” (McKee, 2013). 
4) “Exercise and Parkinson’s: benefits for cognition and quality of life” (Cruise, 
2011). 
5) “Can exercise improve language and cognition in Parkinson’s disease? A case re-
port” (Nocera, 2010). 
6) “Efficacy of a multimodal cognitive rehabilitation including psychomotor and en-
durance training in Parkinson’s disease” (Reuter, 2012). 
7)”Intensive Rehabilitation Increases BDNF Serum Levels in Parkinsonian Patients: 
a Randomized Study” (Frazzitta, 2014). 
